|
1
|
Smith RE and Ashiya M: Antihypertensive
therapies. Nat Rev Drug Discov. 6:597–598. 2007.PubMed/NCBI View
Article : Google Scholar
|
|
2
|
Gu Q, Paulose-Ram R, Dillon C and Burt V:
Antihypertensive medication use among US adults with hypertension.
Circulation. 113:213–221. 2006.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Dunlap ME and Peterson RC: ACE inhibitors
vs ARBs: Is one class better for heart failure. Cleve Clin J Med.
69:433–438. 2002.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Cicardi M, Zingale LC, Bergamaschini L and
Agostoni A: Angioedema associated with angiotensin-converting
enzyme inhibitor use: Outcome after switching to a different
treatment. Arch Intern Med. 164:910–913. 2004.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Banerji A, Clark S, Blanda M, LoVecchio F,
Snyder B and Camargo CA Jr: Multicenter study of patients with
angiotensin-converting enzyme inhibitor-induced angioedema who
present to the emergency department. Ann Allergy Asthma Immunol.
100:327–332. 2008.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Nussberger J, Cugno M and Cicardi M:
Bradykinin-mediated angioedema. N Engl J Med. 347:621–622.
2002.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Morimoto T, Gandhi TK, Fiskio JM, Seger
AC, So JW, Cook EF, Fukui T and Bates DW: An evaluation of risk
factors for adverse drug events associated with
angiotensin-converting enzyme inhibitors. J Eval Clin Pract.
10:499–509. 2004.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Hoover T, Lippmann M, Grouzmann E, Marceau
F and Herscu P: Angiotensin converting enzyme inhibitor induced
angio-oedema: A review of the pathophysiology and risk factors.
Clin Exp Allergy. 40:50–61. 2010.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Terreehorst I, Reitsma S and Cohn DM:
Current treatment of Angioedema induced by ACE inhibitors. Curr
Treat Options Allergy. 6:18–26. 2019.
|
|
10
|
Gabb GM, Ryan P, Wing LM and Hutchinson
KA: Epidemiological study of angioedema and ACE inhibitors. Aust N
Z J Med. 26:777–782. 1996.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Cicardi M, Aberer W, Banerji A, Bas M,
Bernstein JA, Bork K, Caballero T, Farkas H, Grumach A, Kaplan AP,
et al: HAWK under the patronage of EAACI (European Academy of
Allergy and Clinical Immunology): Classification, diagnosis, and
approach to treatment for angioedema: Consensus report from the
Hereditary Angioedema International Working Group. Allergy.
69:602–616. 2014.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Craig TJ, Bernstein JA, Farkas H, Bouillet
L and Boccon-Gibod I: Diagnosis and treatment of
bradykinin-mediated angioedema: Outcomes from an angioedema expert
consensus meeting. Int Arch Allergy Immunol. 165:119–127.
2014.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Nedelea I and Deleanu D: Isolated
angioedema: An overview of clinical features and etiology (Review).
Exp Ther Med. 17:1068–1072. 2019.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Agostoni A, Cicardi M, Cugno M, Zingale
LC, Gioffré D and Nussberger J: Angioedema due to
angiotensin-converting enzyme inhibitors. Immunopharmacology.
44:21–25. 1999.
|
|
15
|
Zingale LC, Beltrami L, Zanichelli A,
Maggioni L, Pappalardo E, Cicardi B and Cicardi M: Angioedema
without urticaria: A large clinical survey. CMAJ. 175:1065–1070.
2006.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Lombardi C, Crivellaro M, Dama A, Senna G,
Gargioni S and Passalacqua G: Are physicians aware of the side
effects of angiotensin-converting enzyme inhibitors?: A
questionnaire survey in different medical categories. Chest.
128:976–979. 2005.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Shakib S, Caughey GE, Fok JS and Smith WB:
Adverse drug reaction classification by health professionals:
Appropriate discrimination between allergy and intolerance? Clin
Transl Allergy. 9(18)2019.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Leru PM: Drug allergies in primary care
practice in Romania: A questionnaire-based survey. Allergy Asthma
Clin Immunol. 10(16)2014.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Aberer W: Angioedema is not just ‘deep
urticaria’ but an entity of its own. Allergy. 69:549–552.
2014.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Agostoni A and Cicardi M: Drug-induced
angioedema without urticaria. Drug Saf. 24:599–606. 2001.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Cicardi M and Zanichelli A: Acquired
angioedema. Allergy Asthma Clin Immunol. 6(14)2010.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Schiller PI, Messmer SL, Haefeli WE,
Schlienger RG and Bircher AJ: Angiotensin-converting enzyme
inhibitor-induced angioedema: Late onset, irregular course, and
potential role of triggers. Allergy. 52:432–435. 1997.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Krogh Nielsen T, Bygum A and Rye Rasmussen
E: Life-threatening angio-oedema after the first dose of an ACE
inhibitor-not an anaphylactic reaction. BMJ Case Rep. 2016(pii:
bcr2016214364)2016.doi: 10.1136/bcr-2016-214364. PubMed/NCBI View Article : Google Scholar
|
|
24
|
Dean DE, Schultz DL and Powers RH:
Asphyxia due to angiotensin converting enzyme (ACE) inhibitor
mediated angioedema of the tongue during the treatment of
hypertensive heart disease. J Forensic Sci. 46:1239–1243.
2001.PubMed/NCBI
|
|
25
|
Makani H, Messerli FH, Romero J,
Wever-Pinzon O, Korniyenko A, Berrios RS and Bangalore S:
Meta-analysis of randomized trials of angioedema as an adverse
event of renin-angiotensin system inhibitors. Am J Cardiol.
110:383–391. 2012.PubMed/NCBI View Article : Google Scholar
|
|
26
|
McDowell SE, Coleman JJ and Ferner RE:
Systematic review and meta-analysis of ethnic differences in risks
of adverse reactions to drugs used in cardiovascular medicine. BMJ.
332:1177–1181. 2006.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Leru PM, Anton VF and Bumbea H: Nine year
follow-up of a rare case of angioedema due to acquired C1-inhibitor
deficiency with late onset and good response to attenuated
androgen. Allergy Asthma Clin Immunol. 14(69)2018.PubMed/NCBI View Article : Google Scholar
|
